Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer
Clinical trial NCT06156761 · UNKNOWN
Trial details
- NCT number
- NCT06156761
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-28
- Primary completion
- 2024-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.